Drugdiscovery >> Clinical Trials >> News
3151
Views
New Lymphoma Trial was announced in the UK - drugdiscovery.com
New Lymphoma Trial was announced in the UK - drugdiscovery.com


The body’s own immune system is going to be used for treating Lymphoma in the new method; the clinical trial of which was announced by Cancer Research UK’s Drug Development Office. The body's own defence system is going to attack the cancerous B-cell, which have grown out of control.
Read More >>


Tags: B-cells, ancer Research UK’s Drug Development Office, immune system, Lymphoma, clinical trial - January 29, 2014
Related Articles
5623
Views
Edison Pharmaceuticals announces Phase 2 trial of EPI-743 Edison Pharmaceuticals announces Phase 2 trial of EPI-743
A trial is a double-blind, placebo-controlled crossover study of EPI-743 in patients with defined or undefined genetic diagnoses that feature cellular oxidation/reduction or energy production defects. Read More >>

Tags: Edison, clinical trial, EPI-743, disorders of energy utilization, oxidation-reduction

3731
Views
CCL Clinical trial through the eyes of a patient CCL Clinical trial through the eyes of a patient
ABT-199 is a chronic lymphocytic leukemia (CLL) drug at Phase 1. Harley Hudson is taking part in the trial and hopes to get at least a long term solution for his illness. Read More >>

Tags: solution, illness, CLL, chronic lymphocytic leukemia, clinical trial, cancer

6942
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

3198
Views
The biggest heart-trial takes place The biggest heart-trial takes place
The biggest heart-related clinical trial is going to take place in London. Stem cell technology is going to be tested on patient, some of whom has already gone through heart-attack. Read More >>

Tags: heart attack, stem cell, clinical trial

2339
Views
MediciNova’s drug MN-166 heads to trial for alcohol dependence MediciNova’s drug MN-166 heads to trial for alcohol dependence
MediciNova Inc. a biopharmaceutical company, announced that the National Institute on Alcohol Abuse and Alcoholism will fund a clinical trial of its drug MN-166 (ibudilast) for alcohol addiction. The Read More >>

Tags: MN-166, ibudilast, alcohol, addiction, methamphetamine, opioid, dependence, clinical trial, MediciNova

5269
Views
Patient enrollment in Phase 3 EPIC trial of Iclusig for CML Patient enrollment in Phase 3 EPIC trial of Iclusig for CML
ARIAD Pharmaceuticals’s drug Iclusig (ponatinib) will be compared for efficasy with imatinib in a Phase 3 trial in adult patients with newly diagnosed chronic myeloid leukemia (CML). ARIAD has enrol Read More >>

Tags: Ariad, iclusig, ponatinib, EPIC, clinical trial, CML, chronic myeloid leukemia

3097
Views
Additional data from Talimogene melanoma trial Additional data from Talimogene melanoma trial
Amgen’s Talimogene laherparepvec, a novel oncolytic immunotherapy shows promising results in patients with unresected stage IIIB, IIIC or IV melanoma in a Phase 3 trial. Read More >>

Tags: talimogene, melanoma, oncolytic immunotherapy, clinical trial, Amgen

3443
Views
N30 Pharma starts a new trial for oral cystic fibrosis drug N30 Pharma starts a new trial for oral cystic fibrosis drug
N30 Phamra started the phase I clinical trial of N9115, a new cystic fibrosis drug.The study is randomized, placebo-controlled, double-blind and reached its final cohort. Read More >>

Tags: Clinical Trial,Cystic Fibrosis, Drugs, Fibrosis, Gene, Genetic, Pharmacokinetics, Placebo, Protein

7312
Views
Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial
The data from DUALT 1 trial show that an investigational therapy IDegLira [Tresiba (insulin degludec)/Victoza (liraglutide injection)] achieved statistically significant greater reduction in blood sug Read More >>

Tags: Novo Nordisk, type 2 diabetes, DUALT 1 trial, IDegLira, Tresiba, insulin degludec, Victoza, liraglutide, combination

8170
Views
Medivir’s bone drug successful in Phase 1 clinical trial Medivir’s bone drug successful in Phase 1 clinical trial
The investigational cathepsin K inhibitor MIV-711, used as the treatment of osteoarthritis and other bone related disorders, has shown to be safe and tolerable at doses where it potently decreased car Read More >>

Tags: Medivir, cathepsin K inhibitor, MIV-711, osteoarthritis, bone, drug, invstigational, clinical trial

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013